Most Recent
Hytera launches High Court challenge in IP dispute with Motorola
Radio manufacturer Hytera wants the High Court to hear its appeal of a finding that it misappropriated Motorola's source code in a case of "substantial industrial theft”.
Sacked ANZ trader largely loses bid to amend case after 11 iterations
A former ANZ trader who was allegedly axed after complaining about manipulation of the bank bill swap rate has largely lost his application to amend his case.
Boral wins challenge to CEO cross-examination in class actions
Boral has won a legal challenge to its former CEO facing cross-examination in a shareholder class action trial over an email referring to a confidential EY report. 
Hytera can’t dodge ‘substantial industrial theft’ finding in Motorola case
An appeals court has rejected Chinese radio manufacturer Hytera’s challenge to a finding it misappropriated the source code of US mobile phone giant Motorola.
Cipla loses bid to cut short Novo Nordisk’s weight loss drug patent
Indian drug maker Cipla has lost a challenge to the extension of Novo Nordisk’s patent for Victoza, with a judge rejecting an argument that extensions can be granted only for active ingredients.
Zoetis loses appeal over pig vaccine patents
US animal drug manufacturer Zoetis has lost its challenge a ruling that chucked out three of its patents for a single-dose vaccine to protect pigs from enzootic pneumonia.
Seven settles lawsuit by ex-Spotlight reporter
Seven Network has resolved a workplace lawsuit by former Spotlight reporter Amelia Saw, but the details of the settlement, like the case itself, are under wraps.
Court clarifies licensing regime in win for offshore wind project
A judge has overturned energy minister Chris Bowen's refusal to greenlight energy company Seadragon’s offshore wind farm project off the coast of Gippsland.
ATO, PepsiCo fight over royalty withholding tax goes to High Court
The ATO has won the nod from the High Court to appeal a finding that a royalty withholding tax did not apply to payments from Schweppes to PepsiCo under agreements to sell brands like Pepsi and Gatorade in Australia.
Cipla attacks patent extension for Novo Nordisk weight loss drug
Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.